Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001278819-04-000017
Filing Date
2004-05-17
Accepted
2004-05-17 14:54:05
Documents
1
Period of Report
2004-05-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5181
  Complete submission text file 0001278819-04-000017.txt   7305
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TEN POST OFFICE SQUARE BOSTON MA 02109
Business Address C/O STONEBRIDGE ASSOCIATES LLC TEN POST OFFICE SQUARE BOSTON MA 02109 6173571770
JENCKES LINDA (Reporting) CIK: 0001235479 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-04829 | Film No.: 04811754